Chemed (NYSE:CHE) Updates FY 2026 Earnings Guidance

Chemed (NYSE:CHE) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 23.250-24.250 for the period, compared to the consensus EPS estimate of 23.420. The company issued revenue guidance of -.

Chemed Trading Down 0.4%

Shares of CHE stock traded down $1.70 during trading hours on Wednesday, hitting $466.62. 248,918 shares of the company’s stock were exchanged, compared to its average volume of 165,709. The company has a market capitalization of $6.61 billion, a PE ratio of 24.68, a PEG ratio of 2.33 and a beta of 0.44. Chemed has a 12-month low of $408.42 and a 12-month high of $623.60. The business’s 50 day simple moving average is $446.53 and its 200-day simple moving average is $444.22.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The company had revenue of $639.34 million during the quarter, compared to analysts’ expectations of $659.09 million. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Equities analysts anticipate that Chemed will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be issued a $0.60 dividend. The ex-dividend date is Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio is 12.69%.

Analysts Set New Price Targets

Several brokerages recently issued reports on CHE. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Finally, Royal Bank Of Canada lowered their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $555.50.

Hedge Funds Weigh In On Chemed

Several large investors have recently modified their holdings of CHE. AQR Capital Management LLC lifted its holdings in shares of Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after buying an additional 153,469 shares during the period. Victory Capital Management Inc. lifted its holdings in Chemed by 1,260.2% in the fourth quarter. Victory Capital Management Inc. now owns 117,685 shares of the company’s stock valued at $50,353,000 after acquiring an additional 109,033 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in Chemed by 740.9% in the third quarter. Arrowstreet Capital Limited Partnership now owns 95,573 shares of the company’s stock worth $42,792,000 after purchasing an additional 84,208 shares during the last quarter. Epoch Investment Partners Inc. boosted its position in Chemed by 29.4% in the third quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock worth $137,579,000 after purchasing an additional 69,878 shares during the last quarter. Finally, Millennium Management LLC grew its stake in shares of Chemed by 72.4% during the 4th quarter. Millennium Management LLC now owns 137,146 shares of the company’s stock valued at $58,679,000 after purchasing an additional 57,614 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.